Joseph Michael Warusz's Net Worth
$37.8 Thousand
Who is Joseph Michael Warusz?
Joseph Michael Warusz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alliqua BioMedical, Inc., SOLIGENIX, INC., and NOVADEL PHARMA INC.
SEC CIK
Joseph Michael Warusz's CIK is 0001468000
Past Insider Trading and Trends
2014 was Joseph Michael Warusz's most active year for acquiring shares with 4 total transactions. Joseph Michael Warusz's most active month to acquire stocks was the month of November. 2014 was Joseph Michael Warusz's most active year for disposing of shares, totalling 1 transactions. Joseph Michael Warusz's most active month to dispose stocks was the month of April. 2014 saw Joseph Michael Warusz paying a total of $13,002.25 for 62,914 shares, this is the most they've acquired in one year. In 2014 Joseph Michael Warusz cashed out on 4,690 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alliqua BioMedical, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLIGENIX, INC. (SNGX) Snapshot price: $3.92
VP Finance/Acting CFOJoseph Michael Warusz owns 12,955 units of Common Stock which is worth $50,783.60. In the year 2011 Joseph Michael Warusz filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +176.23% | 8.27K |
$1.21 | $10,000.65 | 12.96K |
Dec 22 - Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
|
∞
| 4.69K |
$0.64 | $3,001.60 | 4.69K |
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVADEL PHARMA INC No price found
Principal Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||